3-methyl-2-oxobutanoic acid
Common Name: |
3-methyl-2-oxobutanoic acid |
IUPAC Name: |
2-oxobutanoic acid |
Molecular Formula: |
C5H8O3 |
SMILES: |
CC(C)C(=O)C(=O)O |
Inchi: |
1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8) |
Inchi Key: |
QHKABHOOEWYVLI-UHFFFAOYSA-N |
Cas No: |
759-05-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
116.12 |
Mass (g/mol) |
116.047 |
Molar Refractivity |
28.12 |
Net Charge |
-1 |
HBD |
1 |
HBA |
3 |
Rt Bonds |
2 |
Rings |
|
TPSA |
54.37 |
Hetero Atoms |
3 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
31.5 |
Boiling Point (°C@760.00mm Hg) |
170.00 to 171.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.732 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
0.296 |
iLOGP |
0.77 |
XLOGP3 |
0.71 |
WLOGP |
0.30 |
MLOGP |
-0.09 |
ESOL Log S |
-0.88 |
ESOL Solubility (mg/ml) |
15.5 |
ESOL Solubility (mol/l) |
0.133 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.43 |
Ali Solubility (mg/ml) |
4.32 |
Ali Solubility (mol/l) |
0.04 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
0.03 |
Silicos-IT Solubility (mg/ml) |
124 |
Silicos-IT Solubility (mol/l) |
1.07 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.50 |
Bioavailability Score |
0.85 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.605 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.697 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |